IL18 signaling causes islet β cell development and insulin secretion via different receptors on acinar and β cells
Xian Zhang,Songyuan Luo,Minjie Wang,Qin Huang,Wenqian Fang,Jie Li,Tianxiao Liu,Yuanyuan Zhang,Zhiyong Deng,Cong-Lin Liu,Shuling Guan,Julio E. Ayala,Richard A. Flavell,Rohit N. Kulkarni,Peter Libby,Junli Guo,Zhangsuo Liu,Guo-Ping Shi
DOI: https://doi.org/10.1016/j.devcel.2022.05.013
IF: 13.417
2022-06-20
Developmental Cell
Abstract:Diabetic patients show elevated plasma IL18 concentrations. IL18 has two receptors: the IL18 receptor (IL18r) and the Na-Cl co-transporter (NCC). Here, we report that IL18 is expressed on islet α cells, NCC on β cells, and IL18r on acinar cells in human and mouse pancreases. The deficiency of these receptors reduces islet size, β cell proliferation, and insulin secretion but increases β cell apoptosis and exocrine macrophage accumulation after diet-induced glucose intolerance or streptozotocin-induced hyperglycemia. Together with the glucagon-like peptide-1 (GLP1), IL18 uses the NCC and GLP1 receptors on β cells to trigger β cell development and insulin secretion. IL18 also uses the IL18r on acinar cells to block hyperglycemic pancreas macrophage expansion. The β cell-selective depletion of the NCC or acinar-cell-selective IL18r depletion reduces glucose tolerance and insulin sensitivity with impaired β cell proliferation, enhanced β cell apoptosis and macrophage expansion, and inflammation in mouse hyperglycemic pancreas. IL18 uses NCC, GLP1r, and IL18r to maintain islet β cell function and homeostasis.
cell biology,developmental biology